| Title | Early detection of Alzheimer's disease with PET imaging. |
| Publication Type | Journal Article |
| Year of Publication | 2010 |
| Authors | Berti V, Osorio RS, Mosconi L, Li Y, De Santi S, de Leon MJ |
| Journal | Neurodegener Dis |
| Volume | 7 |
| Issue | 1-3 |
| Pagination | 131-5 |
| Date Published | 2010 |
| ISSN | 1660-2862 |
| Keywords | Alzheimer Disease, Fluorodeoxyglucose F18, Humans, Positron-Emission Tomography |
| Abstract | Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD. |
| DOI | 10.1159/000289222 |
| Alternate Journal | Neurodegener Dis |
| PubMed ID | 20197691 |
| PubMed Central ID | PMC3214828 |
| Grant List | P30 AG008051 / AG / NIA NIH HHS / United States R01 AG013616 / AG / NIA NIH HHS / United States R01 AG022374 / AG / NIA NIH HHS / United States |
Related Institute:
Brain Health Imaging Institute (BHII)